Specific pharmacological inhibitors of the mTOR signaling pathway may be used for anti-inflammatory therapy in several inflammation-related diseases, such as cancer, neurodegenerative diseases, atherosclerosis, sepsis and rheumatoid arthritis [144]. This evidence concerns the gene MTOR and Sepsis.